Vir Biotechnology, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vir Biotechnology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Vir Biotechnology, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 18,900 | 28,917 | 353,355 | |
| Feb 25 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 63.74 | 7,900 | 503,577 | 74,200 | 82.1 K to 74.2 K (-9.62 %) |
| Feb 25 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 18,900 | 28,917 | 82,100 | 63.2 K to 82.1 K (+29.91 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Option Exercise | A | 67.38 | 50,000 | 3,369,000 | 50,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Horn Howard | CFO | Grant | A | 0.00 | 25,000 | 0 | 202,777 | 177.8 K to 202.8 K (+14.06 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | A | 67.38 | 60,000 | 4,042,800 | 60,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Grant | A | 0.00 | 30,000 | 0 | 63,200 | 33.2 K to 63.2 K (+90.36 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | A | 67.38 | 64,000 | 4,312,320 | 64,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 0.86 | 10,000 | 8,550 | 33,833 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Grant | A | 0.00 | 32,000 | 0 | 109,277 | 77.3 K to 109.3 K (+41.41 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 0.86 | 10,000 | 8,550 | 77,277 | 67.3 K to 77.3 K (+14.86 %) |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Rice Steven J. | Chief Administrativ ... | Option Exercise | A | 67.38 | 40,000 | 2,695,200 | 40,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | Rice Steven J. | Chief Administrativ ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Option Exercise | A | 67.38 | 222,000 | 14,958,360 | 222,000 | |
| Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Grant | A | 0.00 | 111,000 | 0 | 4,609,559 | 4.5 M to 4.6 M (+2.47 %) |
| Feb 17 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Option Exercise | M | 0.86 | 10,000 | 8,550 | 43,833 | |
| Feb 17 2021 | VIR | Vir Biotechnology, ... | Pang Phillip | Chief Medical Offic ... | Buy | M | 0.86 | 10,000 | 8,550 | 67,277 | 57.3 K to 67.3 K (+17.46 %) |
| Feb 10 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Option Exercise | M | 1.53 | 7,900 | 12,087 | 372,255 | |
| Feb 10 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Sell | S | 71.16 | 7,900 | 562,161 | 33,200 | 41.1 K to 33.2 K (-19.22 %) |
| Feb 10 2021 | VIR | Vir Biotechnology, ... | Virgin Herbert | EVP, Research & CSO | Buy | M | 1.53 | 7,900 | 12,087 | 41,100 | 33.2 K to 41.1 K (+23.80 %) |